Background We assessed effectiveness, safety, and tolerability of paclitaxel or fluorouracil
when added to radiation plus cisplatin followed by adjuvant chemotherapy in a programme …

Purpose. To assess the safety, tolerance, and efficacy of transurethral surgery plus
concomitant cisplatin, 5-fluorouracil (5-FU), and radiation therapy in conjunction with …

Context Aims of bladder preservation in muscle-invasive bladder cancer (MIBC) are to offer
a quality-of-life advantage and avoid potential morbidity or mortality of radical cystectomy …

PURPOSE: We describe a protocol designed to evaluate the use of twice daily radiation
used together with cisplatin and 5 fluorouracil (5-FU) in the treatment of operable transitional …

Radical cystectomy for invasive bladder cancer remains the standard of care in many parts
of the world, including North America and many parts of Europe; however, a large body of …

OBJECTIVES: To evaluate the safety, tolerance, protocol completion rate, tumor response
rate, and patient survival of chemoradiotherapy for patients with muscle-invasive operable …

Purpose Fluorouracil plus cisplatin and radiation twice a day (FCT) is an established
chemoradiation (CRT) regimen for selective bladder-sparing treatment of muscle-invasive …

Purpose Bladder preservation therapy is an effective treatment for muscle-invasive urothelial
carcinoma (UC). In this study we treated noncystectomy candidates with daily radiation and …

OBJECTIVE: To evaluate the 5-year results of the following trimodal therapy for treatment of
some selected cases of muscle invasive bladder cancer. MATERIALS AND METHODS: In …

Background BC2001 demonstrated improved local control with the addition of
chemotherapy to radiotherapy in 360 patients with muscle-invasive bladder cancer …